• Japanese
  • Korean
  • Chinese
Cover Image

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014

GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restless Legs Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Restless Legs Syndrome 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Unaccomplished Trials of Restless Legs Syndrome 25
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Restless Legs Syndrome Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • C. H. Boehringer Sohn AG & Co. KG 33
  • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 33
  • UCB S.A. 36
  • Clinical Trial Overview of UCB S.A. 36
  • GlaxoSmithKline plc 38
  • Clinical Trial Overview of GlaxoSmithKline plc 38
  • XenoPort, Inc. 40
  • Clinical Trial Overview of XenoPort, Inc. 40
  • Pfizer Inc. 41
  • Clinical Trial Overview of Pfizer Inc. 41
  • Otsuka Holdings Co., Ltd. 42
  • Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42
  • Impax Laboratories, Inc. 43
  • Clinical Trial Overview of Impax Laboratories, Inc. 43
  • Daiichi Sankyo Company, Limited 44
  • Clinical Trial Overview of Daiichi Sankyo Company, Limited 44
  • Astellas Pharma Inc. 45
  • Clinical Trial Overview of Astellas Pharma Inc. 45
  • Boehringer Ingelheim Auslandsbeteiligungs GmbH 46
  • Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 46
  • Clinical Trial Overview of Top Institutes / Government 47
  • National Institute of Neurological Disorders and Stroke 47
  • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 47
  • Brigham and Women's Hospital 48
  • Clinical Trial Overview of Brigham and Women's Hospital 48
  • Johns Hopkins University 49
  • Clinical Trial Overview of Johns Hopkins University 49
  • Massachusetts General Hospital 50
  • Clinical Trial Overview of Massachusetts General Hospital 50
  • University of South Florida 51
  • Clinical Trial Overview of University of South Florida 51
  • Instituto de Investigaciones del Sueno 52
  • Clinical Trial Overview of Instituto de Investigaciones del Sueno 52
  • Nanjing Medical University 53
  • Clinical Trial Overview of Nanjing Medical University 53
  • Children's Hospitals and Clinics of Minnesota 54
  • Clinical Trial Overview of Children's Hospitals and Clinics of Minnesota 54
  • University Hospital, Bordeaux 55
  • Clinical Trial Overview of University Hospital, Bordeaux 55
  • National Institute on Aging 56
  • Clinical Trial Overview of National Institute on Aging 56
  • Five Key Clinical Profiles 57

Appendix 147

  • Abbreviations 147
  • Definitions 147
  • Research Methodology 148
  • Secondary Research 148
  • About GlobalData 149
  • Contact Us 149
  • Disclaimer 149
  • Source 149

List of Tables

  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region, 2014* 7
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
  • Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
  • Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
  • Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
  • Restless Legs Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014* 21
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Restless Legs Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
  • Restless Legs Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014* 26
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 33
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 36
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by XenoPort, Inc., 2014* 40
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 41
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 42
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Impax Laboratories, Inc., 2014* 43
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 44
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 45
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 46
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 47
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 48
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 49
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 50
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 51
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto de Investigaciones del Sueno, 2014* 52
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014* 53
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospitals and Clinics of Minnesota, 2014* 54
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 55
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 56

List of Figures

  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
  • Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
  • Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
  • Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • GlobalData Methodology 148
Show More
Pricing
Get Notified
Email me when related reports are published